Precision Health and PGx Podcast

Thanks for joining us today as our host, Dr. Jamie Wilkey talks with a patient, Kristen, who strongly feels that PGx testing saved her life.  Join us for a patient’s side of the story today! You may reach Kristen at her website: https://www.imnotcrazyproject.org/ her Facebook page: https://www.facebook.com/imnotcrazyproject or on LinkedIn: https://www.linkedin.com/in/kristen-ruth-davis-5540142a/ Y...

According to the American Academy of Family Physicians, there are more than 50 Cytochrome P450 enzymes but there are just 6 of them that metabolize about 90% of the drugs. One of the most significant ones is the CYP2D6. In an article on healio written by Dr. Jai Patel, he talks about CYP2D6 metabolizing many of the SSRIs, SNRIs and TCAs that are the treatment options for depression. The clearance...

On this episode, Dr. Gillian Bell, a Doctor of Clinical Pharmacy, shares her path from pharmacy school to her non-traditional PharmD job as Pharmacogenomics Lead, Genome Medical.  On This Episode We Discuss:  • Gillian’s education (Brief)  • Gillian’s PharmD work experience prior to PGx (Brief) Residency  • Gillian’s PGx work experience prior to Genome Medical (Brief) Mission Hospital  • Brief des...

According to the National Community Pharmacists Association (NCPA), community pharmacists are highly accessible health care professionals and 95% of Americans live within just 5 miles of a pharmacy. (https://ncpa.org/provider-status) And what APhA or American Pharmacist Association, the largest association of pharmacists in the US is doing is laser focusing on getting provider status for pharmacis...

Pharmacogenomics Market Access and Reimbursement Series Episode Description:   Most of us understand that the reimbursement for pharmacogenomics tests has been one barrier amongst many barriers to pharmacogenomics’ wide-scale clinical adoption. Finding myself highly frustrated with the slow clinical uptake by PGx test ordering by healthcare providers back in 2017, I brainstormed about which payers...

Today’s episode is the 3rd episode in my PGx for Pharmacists Podcast series entitled, “The State of the PGx Industry: Pharmacogenomics Science and Research". I am super honored that, yet another one of my pharmacogenomics science expert colleagues is joining me on the podcast to provide my audience with high quality, evidence-based pharmacogenomics content. Today’s guest just so happens to be join...

Dr. Samit Shah serves as the Dean of the Regis University School of Pharmacy. Dr. Shah also served as the Assistant Dean and Department Chair of Biopharmaceutical Sciences at KGI SPHS. Dr. Shah earned a BS in pharmacy from North Gujarat University, a PhD in pharmaceutical sciences from the University of Missouri-Kansas City (UMKC), and an MBA from South University. He received post-doctoral traini...

On this episode of the PGx for Pharmacists Podcast, Dr. Codi Peterson, a Doctor of Clinical Pharmacy and pediatric pharmacist, and discusses what was once a taboo subject for pharmacists and that is cannabis. We will explore how pharmacy has and hasn’t progressed in its acceptance of cannabis over the years, what roles Codi plays in the cannabis industry, how he has often had to make clinical deci...

Amina Abubakar, PharmD, AAHIVP CEO of Avant Pharmacy & Wellness Center President of Avant Institute Amina Abubakar graduated from the Philadelphia College of Pharmacy University of the Sciences in 2005. She is the owner and manager of Avant Pharmacy & Wellness Center formerly known as Rx Clinic Pharmacy in Charlotte, NC, and the founder of the Avant Institute. She is an internationally recognized...

Our special guest & newest host of the PGX for Pharmacists Podcast, Nancy Gadelsayed BS, RPh. Nancy Graduated pharmacy school from Cairo university in 2005, top %10 of her class, with 3.9 GPA She has been practicing as a pharmacist in the States since 2007, with passion for personalized medicine. She is currently a pharmacy manager at a big retail company and is also the founder and owner of Texas...

According to the American Association for Cancer Research, 80-90% of the administered dose of the cancer medication 5-fluorouracil of 5FU is degraded by the enzyme dihydropyridine dehydrogenase or DPD for short. (https://clincancerres.aacrjournals.org/content/5/8/2006). According to the Institute of Safe Medication Practices (www.ismp.org/resources/screening-dihydropyrimidine-dehydrogenase-dpd-def...

Jamie grew up in a small town in Wyoming where she got her start in pharmacy working at the local City Drug. She attended the University of Wyoming School of Pharmacy for her Doctor of Pharmacy. For 10 years post-graduation Jamie worked in community pharmacy while having and raising her 4 little boys. However, a young family and community pharmacy work schedules are not highly compatible, so in 20...

Implementing Pharmacogenomics into the Education of the PharmD  How do interested faculty start a program for PGx education at their own school? Today’s episode builds on the experiences of David Hurley in developing a PGx program at the Gatton College of Pharmacy. His training provides ALL first year students with free PGx testing coordinated with Biochemistry coursework. As we will discuss, maki...

How can we leverage pharmacists to help patients transition better and also allow the providers use the expertise of pharmacists? According to the peer review journal JAMA (Journal of American Medical Association), to improve care when patients transition from a facility such as a hospital to their home, Medicare started reimbursing for what is called the Transition of Care in 2013. It still has a...

Dr. Jessica Whelan has extensive experience in the mental health field and has served as a speaker and advisory board member in many areas including psychopharmacology and pharmacogenomics. Dr. Whelan is the CEO of a national network of clinicians with Holon Inclusive Health System and adjunct faculty at Maryville University. She supports multiple universities to provide clinical mentorship for me...

ALVA10: the Power of Diagnostics  Have you ever questioned why a payer pays for a medication, yet does not pay for the diagnostic test to determine if the medication will be efficacious and non-toxic for the patient? Or perhaps, you may have wondered why payers agree to pay for a medication for which no diagnostic test exists to diagnose the condition the medication treats?  If these types of ques...

Today's episode of the PGX for Pharmacists podcast is hosted by Dr. Becky Winslow, PharmD. Dr. Winslow is a pharmacogenomics authority with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven years of pharmacy management experience and six years of experience as a medical science liaison in...

DeLon Canterbury is a Board Certified Geriatric Pharmacist.  He founded GeriatRx, a telehealth-based senior care consulting company.  GeriatRx combines Pharmacogenomic testing and Comprehensive Medication Management. He addresses the social determinants of health. He helps reduce medication errors and advocates for de-prescribing. Dr. DeLon helps improve patient safety and saves patients, their fa...

PART TWO: Pharmacogenomics Education is critical to advancing the Pharmacist's optimal impact on medication management as a tool to ensure the drugs prescribed work as intended.  The State of the Industry -- Pharmacogenomics Education Clinical pharmacogenomics activities may include designing patient-specific drug and dosage regimens based on genetic profile, documenting clinical recommendations,...

Dr. Jai Patel, PharmD, BCOP, CPP Chair of Department of Cancer Pharmacology & Pharmacogenomics Dr. Jai Patel is a pharmacist who help create a pharmacogenomics fellowship which was not available at his school. He finished the Oncology/Pharmacogenomics Postdoctoral Fellowship at the UNC Eshelman School of Pharmacy. Dr. Patel: “I approached my mentor and said, ‘this is what I want to practice. I hav...

Pharmacogenomics Education is critical to advancing the Pharmacist's optimal impact on medication management as a tool to ensure the drugs prescribed work as intended.  The State of the Industry -- Pharmacogenomics Education Clinical pharmacogenomics activities may include designing patient-specific drug and dosage regimens based on genetic profile, documenting clinical recommendations, educating...

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting. 

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, Maci Koesterer, PharmD candidate 2021 from St. Louis College of Pharmacy where we discuss her first virtual and unique rotation in PGx and her recommendations to other students.

Behnaz Sarrami, MS, PharmD, an entrepreneur and a coach in PGx who has started her own consulting business bringing awareness to the clinical value and utility of PGx to providers, pharmacists, and consumers.

Kristine Ashcraft, BS, MBA is a molecular biologist by training and is the former CEO and founder of YouScript, recently acquired by Invitae. She has worked in pharmacogenomics since 2000 and was recently named one of the 25 leading voices in precision medicine. Kristine has authored multiple publications on the clinical and economic benefits of pharmacogenomic testing including one lauded as one...